관절경 검사 기기 시장 보고서 : 기기 종류별, 관절경 종류별, 최종사용자별, 지역별(2025-2033년)

The global arthroscopy devices market size reached USD 5.2 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 9.2 Billion by 2033, exhibiting a growth rate (CAGR) of 6.53% during 2025-2033.

Arthroscopy devices refer to various medical equipment and tools that are used to visualize, examine and conduct therapeutic interventions inside various joints of the body. They are primarily used for the treatment of medical conditions, such as osteoarthritis, rheumatoid arthritis, tendonitis and bone tumor. Some of the commonly used devices during arthroscopy include arthroscope, implants, fluid management systems, radiofrequency systems, visualization systems, etc. These devices are usually attached with a small lens and are inserted into the patient's body to examine the structures and abnormalities inside the joints. These devices find extensive application in the arthroscopy of the knee, hip, spine, ankle, shoulder, elbow, wrist and jaw.

The increasing prevalence of bone-related and musculoskeletal disorders is one of the key factors driving the growth of the market. Furthermore, the rising geriatric population across the globe that is more susceptible to such ailments is also providing a boost to the market growth. There is an increasing preference for minimally invasive (MI) treatment procedures among the masses, which has led to the rising adoption of arthroscopy devices. Additionally, various innovations in the field of sports medicine and the development of technologically advanced product variants are also creating a positive outlook for the market. Product manufacturers are developing advanced arthroscopic devices to improve visualization with high-definition (HD) cameras, superior suturing techniques and customized suturing materials. Other factors, including rising health consciousness and awareness regarding the available treatment alternatives, along with the improving healthcare infrastructure, are projected to drive the market further.

Key Market Segmentation:

Breakup by Device Type:

• Arthroscope
• Arthroscopic Implant
• Fluid Management System
• Radiofrequency System
• Visualization System
• Others

Breakup by Arthroscopy Type:

• Knee Arthroscopy
• Hip Arthroscopy
• Spine Arthroscopy
• Shoulder and Elbow Arthroscopy
• Foot and Ankle Arthroscopy
• Others

Breakup by End-User:

• Hospitals
• Ambulatory Surgical Centers
• Orthopedic Clinics
• Others

Breakup by Region:

• North America
  • United States
  • Canada
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Arthrex Inc., CONMED Corporation, Johnson & Johnson Services Inc, Karl Storz SE & Co. KG, Medtronic Inc., Richard Wolf GmbH, Smith & Nephew plc, Stryker Corporation, Vimex Sp. z o.o., Zimmer Biomet Holdings Inc., etc.

Key Questions Answered in This Report

• 1.What was the size of the global arthroscopy devices market in 2024?
• 2.What is the expected growth rate of the global arthroscopy devices market during 2025-2033?
• 3.What has been the impact of COVID-19 on the global arthroscopy devices market?
• 4.What are the key factors driving the global arthroscopy devices market?
• 5.What is the breakup of the global arthroscopy devices market based on the device type?
• 6.What is the breakup of the global arthroscopy devices market based on the arthroscopy type?
• 7.What is the breakup of the global arthroscopy devices market based on the end-user?
• 8.What are the key regions in the global arthroscopy devices market?
• 9.Who are the key players/companies in the global arthroscopy devices market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Arthroscopy Devices Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Device Type

• 6.1 Arthroscope
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Arthroscopic Implant
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Fluid Management System
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast
• 6.4 Radiofrequency System
  • 6.4.1 Market Trends
  • 6.4.2 Market Forecast
• 6.5 Visualization System
  • 6.5.1 Market Trends
  • 6.5.2 Market Forecast
• 6.6 Others
  • 6.6.1 Market Trends
  • 6.6.2 Market Forecast

7 Market Breakup by Arthroscopy Type

• 7.1 Knee Arthroscopy
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Hip Arthroscopy
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Spine Arthroscopy
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Shoulder and Elbow Arthroscopy
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast
• 7.5 Foot and Ankle Arthroscopy
  • 7.5.1 Market Trends
  • 7.5.2 Market Forecast
• 7.6 Others
  • 7.6.1 Market Trends
  • 7.6.2 Market Forecast

8 Market Breakup by End-User

• 8.1 Hospitals
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Ambulatory Surgical Centers
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Orthopedic Clinics
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Others
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Indicators

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 Arthrex Inc.
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
    • 14.3.1.3 SWOT Analysis
  • 14.3.2 CONMED Corporation
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
    • 14.3.2.3 Financials
    • 14.3.2.4 SWOT Analysis
  • 14.3.3 Johnson & Johnson Services Inc.
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
    • 14.3.3.3 Financials
    • 14.3.3.4 SWOT Analysis
  • 14.3.4 Karl Storz SE & Co. KG
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
    • 14.3.4.3 Financials
    • 14.3.4.4 SWOT Analysis
  • 14.3.5 Medtronic Inc.
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
  • 14.3.6 Richard Wolf GmbH
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
    • 14.3.6.3 Financials
    • 14.3.6.4 SWOT Analysis
  • 14.3.7 Smith & Nephew Plc
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
    • 14.3.7.3 Financials
    • 14.3.7.4 SWOT Analysis
  • 14.3.8 Stryker Corporation
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
    • 14.3.8.3 Financials
    • 14.3.8.4 SWOT Analysis
  • 14.3.9 Vimex Sp. z o.o.
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio
  • 14.3.10 Zimmer Biomet Holdings Inc.
    • 14.3.10.1 Company Overview
    • 14.3.10.2 Product Portfolio
    • 14.3.10.3 Financials
    • 14.3.10.4 SWOT Analysis